Ignite Creation Date:
2025-12-24 @ 4:21 PM
Ignite Modification Date:
2025-12-24 @ 4:21 PM
Study NCT ID:
NCT04417166
Status:
RECRUITING
Last Update Posted:
2025-01-30
First Post:
2020-06-02
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Sponsor:
International Extranodal Lymphoma Study Group (IELSG)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-11
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-02
First Submit QC Date:
None
Study First Post Date:
2020-06-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-29
Last Update Post Date:
2025-01-30
Last Update Post Date Type:
ACTUAL